Future possibilities for the treatment of septic shock with herbal components

American Journal of Emergency Medicine

Volumn 27, Issue 1, 2009, Pages 107-112

  Wang, Houli ^a   Xu, Tengda ^a   Lewin, Matthew R ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANACARDIC ACID; ANDROGRAPHIS PANICULATA EXTRACT; ANTIBIOTIC AGENT; ARTEMISIA ANNUA EXTRACT; ARTEMISININ; ASTRAGALUS MEMBRANACEUS EXTRACT; CHAIHU EXTRACT; DROTRECOGIN; FRUCTUS AURANTII IMMATURUS EXTRACT; FRUCTUS SCHISANDRAE CHINENSIS EXTRACT; HERBA PATRINIAE EXTRACT; HERBACEOUS AGENT; METICILLIN; NASTURTIUM EXTRACT; PANAX NOTOGINSENG EXTRACT; PRUNELLA VULGARIS EXTRACT; RADIX SOPHORAE FLAVESCENTIS EXTRACT; RHUBARB EXTRACT; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BACTERIAL VIRULENCE; BLEEDING; BLOOD VESSEL TONE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; HEPATITIS B; HERBAL MEDICINE; HUMAN; IMMUNE RESPONSE; MALARIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; VIRUS INFECTION;

DRUGS, CHINESE HERBAL; HUMANS; INTESTINES; PHYTOTHERAPY; PLANT PREPARATIONS; SHOCK, SEPTIC;

EID: 56549091287     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.08.003     Document Type: Review

References (60)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 7 (2001) 1303-1310
2. Nguyen H.B., Rivers E.P., Abrahamian F.M., et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48 1 (2006) 28-54
3. Henninger D.D., Panes J., Eppihimer M., et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158 4 (1997) 1825-1832
4. Bratt J., and Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol 159 2 (1997) 912-918
5. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 273 2 (1995) 117-123
6. Hand W.L. Current challenges in antibiotic resistance. Adolesc Med 11 2 (2000) 427-438
7. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Eng J Med 358 2 (2008) 188-190
8. Cole L., Bellomo R., Hart G., et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30 1 (2002) 100-106
9. Eichacker P.Q., Natanson C., and Danner R.L. Surviving sepsis-practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355 16 (2006) 1640-1642
10. Fein A.M., Bernard G.R., Criner G.J., et al. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127): results of a randomized, double-blind, placebo-controlled trial. JAMA 277 6 (1997) 482-487
11. Fisher Jr. C.J., Dhainaut J.F., Opal S.M., et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. JAMA 271 23 (1994) 1836-1843
12. Zeni F., Freeman B., and Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25 7 (1997) 1095-1100
13. Taniguchi M., and Kubo I. Ethnobotanical drug discovery based on medicine men's trials in the African savanna: screening of east African plants for antimicrobial activity II. J Nat Prod 56 9 (1993) 1539-1546
14. Long Y., Lin X.T., Zeng K.L., et al. Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary Pancreatic Dis Int 3 1 (2004) 69-72
15. Yip A.Y., Loo W.T., and Chow L.W. Fructus schisandrae (Wuweizi) containing compound in modulating human lymphatic system-a phase I minimization clinical trial. Biomed Pharmacother 61 9 (2007) 588-590
16. Li S.S., Li H.Y., Piao Y.A., et al. The anti-respiratory syncytial virus effect of an active compound (AP3) from a Chinese medicinal herb-Herba patriniae in vitro. Zhonghua Liu Xing Bing Xue Za Zhi 25 2 (2004) 150-153
17. Wang X., Wang Y., Liu F., et al. The inhibitory effect of decomposed Chinese traditional medicine Chaihu on Coxsackie B virus(CVB3m) replication and its influence on cell activity. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 15 3 (2001) 280-282
18. Xu X.H., Lee S.H., Lee S.F., et al. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res 44 1 (1999) 43-53
19. Yamasaki K., Nakano M., Kawahata T., et al. Anti-HIV-1 activity of herbs in Labiatae. Biol Pharm Bull 21 8 (1998) 829-833
20. Goos K.H., Albrecht U., and Schneider B. Efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in comparison with other treatments in the daily practice/results of a prospective cohort study. Arzneimittelforschung 56 3 (2006) 249-257
21. Lee M.H., Kwon H.A., Kwon D.Y., et al. Antibacterial activity of medicinal herb extracts against Salmonella. Int J Food Microbiol 111 3 (2006) 270-275
22. Coon J.T., and Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med 70 4 (2004) 290-298
23. Muroi H., and Kubo I. Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus. J Appl Bacteriol 80 4 (1996) 380-394
24. Ratcliff A., Siswantoro H., Kenangalem E., et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369 9563 (2007) 757-765
25. Zhao X.W., Li J.X., Zhu Z.R., et al. Anti-shock effects of synthetic effective compositions of Fructus aurantii immaturus. Experimental study and clinical observation. Chin Med J (Engl) 102 2 (1989) 91-93
26. Deitch E.A., XU D., and Kaise V.L. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci 1 11 (2006) 520-528
27. Fink M.P., and Delude R.L. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21 2 (2005) 177-196
28. Han X., Fink M.P., Yang R., et al. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 21 3 (2004) 261-270
29. Hotchkiss R.S., Swanson P.E., Freeman B.D., et al. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med 27 7 (1999) 1230-1251
30. Coopersmith C.M., Stromberg P.E., Dunne W.M., et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287 13 (2002) 1716-1721
31. Doig C.J., Suckerland L.R., Sandham J.D., et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 158 2 (1998) 444-451
32. Gatt M., Reddy B.S., and MacFie J. Bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 25 7 (2007) 741-757
33. Tan B.K., and Vanitha J. Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review. Curr Med Chem 11 11 (2004) 1423-1430
34. Han J.Y., Fan J.Y., Horie Y., et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther. 117 2 (2008) 280-295
35. Wang X., Morris-Natschke S.L., and Lee K.H. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 27 1 (2007) 133-148
36. Peng S.M., Wang S.Z., and Zhao J.P. Effect of rhubarb on inflammatory cytokines and complements in patients with systemic inflammation reaction syndrome and its significance. Zhongguo Zhong Xi Yi Jie He Za Zhi 22 4 (2002) 264-266
37. Ko S.K., Lee S.M., and Whang W.K. Anti-platelet aggregation activity of stilbene derivatives from Rheum undulatum. Arch Pharm Res 22 4 (1999) 401-403
38. Matsuda H., Morikawa T., Toguchida I., et al. Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. Bioorg Med Chem 9 1 (2001) 41-50
39. Loeb A.L., Izzo Jr. N.J., Johnson R.M., et al. Endothelium-derived relaxing factor release associated with increased endothelial cell inositol trisphosphate and intracellular calcium. Am J Cardiol 62 11 (1988) 36G-40G
40. Moon M.K., Kang D.G., Lee J.K., et al. Vasodilatory and anti-inflammatory effects of the aqueous extract of rhubarb via a NO-cGMP pathway. Life Sci 78 14 (2006) 1550-1557
41. Fang X.L., Fang Q., Luo J.J., et al. Effects of crude rhubarb on intestinal permeability in septic patients. Am J Chin Med 35 6 (2007) 929-936
42. Fang X.L., Fang Q., and Luo J.J. Effects of raw rhubarb on plasma d-lactate and procalcitonin expressions in patients with sepsis. Zhongguo Zhong Xi Yi Jie He Za Zhi 26 2 (2006) 128-130
43. Chen Y.H., Lin S.J., Ku H.H., et al. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem 82 3 (2001) 512-521
44. Zhou Z., Liu Y., Miao A.D., et al. Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol 513 1-2 (2005) 1-8
45. Guo J., Sun K., Wang C.S., et al. Protective effects of dihydroxylphenyl lactic acid and salvianolic acid B on LPS-induced mesenteric microcirculatory disturbance in rats. Shock 29 2 (2008) 205-211
46. Han J.Y., Horie Y., Miura S., et al. Compound Danshen injection improves endotoxin-induced microcirculatory disturbance in rat mesentery. World J Gastroenterol 13 26 (2007) 3581-3591
47. Kang B.Y., Chung S.W., Kim S.H., et al. Inhibition of interleukin-12 and interferon-g{cyrillic} production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology 49 3 (2000) 355-361
48. Chen C.P., Yokozawa T., and Chung H.Y. Inhibitory effect of caffeic acid analogues isolated from Salciae militiorrhizae radix against 1, 1-diphenyl-2-picrylhydrazyl radical. Exp Toxicol Pathol. 51 1 (1999) 59-63
49. Li L., Tan R., and Chen W. Salvianolic acid A, a new depside from roots of Salvia miltiorrhiza. Planta Med 50 (1984) 227-228
50. Zhang H.S., and Wang S.Q. Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor-alpha (TNF-alpha)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species. J Mol Cell Cardiol 41 1 (2006) 138-148
51. Lee A.R., Wu W.L., Chang W.L., et al. Isolation and bioactivity of new tanshinones. J Nat Prod. 50 2 (1987) 157-160
52. Cao E.H., Liu X.Q., Wang J.J., et al. Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic Biol Med 20 (1996) 801-806
53. Lin Y.L., Lee T.F., Huang Y.J., et al. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. J Pharm Pharmacol 58 7 (2006) 933-939
54. Wang N., Luo H.W., Niwa M., et al. A new platelet aggregation inhibitor from Salvia miltiorrhiza. Planta Med 55 4 (1989) 390-391
55. Lee D.S., Lee S.H., Noh J.G., et al. Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza bunge. Biosci Biotechnol Biochem 63 12 (1999) 2236-2239
56. Jin U.H., Park S.G., Suh S.J., et al. Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions. Phytother Res 21 2 (2007) 142-148
57. Ng T.B. Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol 58 8 (2006) 1007-1019
58. Lin C.F., Wong K.L., Wu R.S., et al. Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity. Phytother Res 17 9 (2003) 1119-1122
59. Wang J., Xu J., and Zhong J.B. Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 24 4 (2004) 312-316
60. Lam S.K., and Ng T.B. Isolation of a novel thermolabile heterodimeric ribonuclease with antifungal and antiproliferative activities from roots of the sanchi ginseng Panax notoginseng. Biochem Biophys Res Commun 285 2 (2001) 419-423